Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2021
Filter by date:
Showing 973 press releases before 2021
-
Lynparza significantly delayed disease progression as 1st-line maintenance treatment in germline BRCA-mutated metastatic pancreatic cancer
-
Brilinta’s Phase III THEMIS trial met primary endpoint in patients with established coronary artery disease and type-2 diabetes
-
Full-Year 2018 Results
-
US FDA grants Fasenra Orphan Drug Designation for hypereosinophilic syndrome
-
US FDA grants Breakthrough Therapy Designation for potential next-generation RSV medicine MEDI8897
-
EMA grants PRIME eligibility for potential next-generation RSV medicine MEDI8897
-
Forxiga receives positive EU CHMP opinion for the treatment of adults with type-1 diabetes
-
Linzess (linaclotide) approved in China for the treatment of irritable bowel syndrome with constipation
-
AstraZeneca announces organisational changes
-
Phase III OLYMPUS and ROCKIES trials for roxadustat met their primary endpoints in chronic kidney disease patients with anaemia
Latest articles and press releases
All of our latest press releases and articles are available to explore
